Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human ACE Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Enzyme Activity
Supplier: R&D Systems™ 929ZN010
This item is not returnable.
View return policy
Description
Measured by its ability to cleave the fluorogenic peptide substrate, Mca-RPPGFSAFK(Dnp)-OH (Catalog # ES005 ). The specific activity is >1,000 pmol/min/μg, as measured under the described conditions.Specifications
P12821.1 | |
Supplied as a 0.2 μm filtered solution in Tris, NaCl, ZnCl2 and Glycerol. | |
M.W. (Observed): 160-180 kDa, reducing conditions; M.W. (theoretical): 143 kDa | |
10 μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 6 months from date of receipt, -20°C to -70°C as supplied. 3 months, -20°C to -70°C under sterile conditions after opening. | |
<1.0 EU / 1 μg of the protein by the LAL method. | |
Unconjugated | |
>95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Enzyme Activity | |
1636 | |
ACE/CD143 Somatic Form | |
Mouse myeloma cell line, NS0-derived human ACE/CD143 protein Leu30-Leu1261, with a C-terminal 10-His tag | |
Recombinant Human ACE/CD143 Somatic Form is prone to proteolytic cleavage at C-terminus. The predominant form of the purified protein lacks the His tag. | |
ACE | |
Recombinant | |
ACE/CD143 |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction